Ocular Hypertension Pages on BioPortfolio:

BioPortfolio - Eye Color
Clinical Trials Logo. Phase IV Study of TRAVATAN 0.004% in Subjects With Iris Pigmentation Changes, Open-Angle Glaucoma; Ocular Hypertension ...
http://www.bioportfolio.com/indepth/Eye_Color.html...

BioPortfolio - PRN Pharmaceutical Research Network
PURPOSE: To assess the cost-effectiveness of treating ocular hypertension... 15th January, 2008, PRN Pharmaceutical Research Network, LLC, Charleston, ...
http://www.bioportfolio.com/biocorporate/28638-Pharmaceutica...

BioPortfolio - Ophthalmology patents
7410992, Ophthalmic compositions for treating ocular hypertension. 7411029, Prepolymers for improved surface modification of contact lenses ...
http://www.bioportfolio.com/indepth/Ophthalmology/patents.ht...

The emergence of vasopressin receptor antagonists
SR121463 demonstrates therapeutic efficacy in models of cirrhosis and ocular hypertension. This molecule is currently in phase II development for the ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-110226.htm...

BioPortfolio - Eye Abnormalities
Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens, Aniridia; Eye Abnormality; Ocular Hypertension; Open Angle Glaucoma ...
http://www.bioportfolio.com/indepth/Eye_Abnormalities.html...

BioPortfolio's Eye and Vision Conditions Specialized Searches
Ocular Hypertension · Ocular Motility Disorders · Ophthalmology Eye · Ophthalmoplegia · Optic Nerve · Optic Nerve Glioma · Optic Nerve Neoplasms ...
http://www.bioportfolio.co.uk/web/eye.html...

BioPortfolio - Ointments
7414067, Ophthalmic compositions for treating ocular hypertension. 7414068, Benzopyran derivatives substituted with secondary amines including tetrazole,
...
http://www.bioportfolio.com/indepth/Ointments.html...

Biotechnology News Uveitis Anterior eyeg. egp. iontophoresi ...
partner Pfizer had decided not to launch Phase III studies in Asia of an experimental treatment of glaucoma and ocular hypertension. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio.com - BioWeb Macular Edema Cystoid Search
Clinical Studies: In clinical studies of patients with open angle glaucoma or ocular hypertension with a mean baseline IOP of 26 mmHg, the IOP- lowering ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Results from other life science and pharmaceutical sites:

View Study [NEI Clinical Studies]
The Ocular Hypertension Treatment Study (OHTS) is a long-term, ... Ocular hypertensive subjects judged to be at moderate risk of developing primary ...
http://www.nei.nih.gov/neitrials/viewStudyWeb.aspx?id=24...

Bausch & Lomb: Ocular Hypertension
Ocular hypertension is an increase in pressure in the eye that is above the range considered normal, usually greater than 21mm Hg. It is distinguished from
...
http://www.bausch.com/en_US/consumer/concern/ocularhyp.aspx...

Background [NEI Ocular Hypertension Treatment Study (OHTS) Results]
Prior to the Ocular Hypertension Treatment Study, there was no clear evidence as to whether reducing elevated pressure in the eye would delay or prevent the ...
http://www.nei.nih.gov/glaucomaeyedrops/ohts_backg.asp...

The Ocular Hypertension Treatment Study: a randomi...[Arch ...
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary
...
http://www.ncbi.nlm.nih.gov/pubmed/12049574...

Ocular Hypertension Treatment Study (OHTS) Results [NEI]
Home » Results--Ocular Hypertension Treatment Study (OHTS). Ocular Hypertension Treatment Study (OHTS). Results--Ocular Hypertension Treatment Study (OHTS) ...
http://www.nei.nih.gov/glaucomaeyedrops/...

Ocular Hypertension Treatment Study
Ocular Hypertension Treatment Study. Current Principal Investigators & Study ... Ocular Hypertension Treatment StudyWeb Site. http://www.ohts.wustl.edu ...
http://www.nih.gov/news/pr/jun2002/nei-13.doc...

NIH Guide: CLINICAL CENTERS FOR OCULAR HYPERTENSION TREATMENT STUDY
Although the OHTS is designed to study the efficacy and safety of early medical treatment in ocular hypertension, there will be other benefits as well. ...
http://grants.nih.gov/grants/guide/rfa-files/RFA-EY-93-001.h...

Eye - Abstract of article: Graves' orbitopathy: frequency of ...
6 Jun 2008 ... A 3.74% prevalence of ocular hypertension (four patients) and a 2.8% prevalence of glaucoma (three patients) was observed. ...
http://www.nature.com/eye/journal/vaop/ncurrent/abs/eye20081...

Issues in Glaucoma: Ocular Hypertension and Surgical Procedures
Highlights in glaucoma from the AAO 2007 include issues in diagnosis and management of patients with ocular hypertension and the latest in surgical ...
http://www.medscape.com/viewarticle/567286...

Primary Care Screening for Ocular Hypertension and Primary Open ...
Primary Care Screening for Ocular Hypertension and Primary Open-Angle Glaucoma: Evidence Synthesis Prepared for: Agency for Healthcare Research and Quality ...
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.chapter...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.